Chengyu Wang

Chengyu Wang

Auto-generated profile, based on publicly available information

Chengyu Wang

Department of Anaesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
HLHaihai Liang
Haihai Liang
TYTong Yu
Tong Yu
YHYue Han
Yue Han
HJHua Jiang
Hua Jiang
CWChengyu Wang
Chengyu Wang
YGYunyan Gu
Yunyan Gu
An amendment to this paper has been published and can be accessed via the original article.

6 May 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
CXCheng Xu
Cheng Xu
FGFei Gu
Fei Gu
CWChengyu Wang
Chengyu Wang
YLYang Liu
Yang Liu
RCRui Chen
Rui Chen
JLJie Lu
Jie Lu
Background: The median effective analgesic concentration (MEAC; EC50 = effective concentration in 50% patients) of ropivacaine in sciatic nerve block guided by ultrasound (US) required for effective postoperative analgesia following arthroscopic anterior cruciate ligament (ACL) reconstruction has not yet been found. This study aimed to determine the effectiveness of MEAC of 20 ml ropivacaine of postoperative anesthesia for patients after ACL reconstruction. Methods: In total, 29 patients who underwent elective arthroscopic ACL reconstruction were enrolled in this study. All the subjects were given 20 ml of 0.2% ropivacaine for femoral nerve block. A concentration of 20 ml ropivacaine administered to the sciatic nerve was measured by applying the up-and-down sequential method (UDM). The starting concentration was 0.2% in the first patient, and the next patient received decremented 0.025% ropivacaine if the prior patient's postoperative visual analog pain score was <4 in the initial 8 h. Otherwise, the participant was given an incremental dose of 0.025% ropivacaine. The EC50 of ropivacaine was determined by using centered isotonic, linear-logarithmic, exponential regressions, and linear regression. The “goodness of fit” was compared among various models by calculating the residual standard errors. Results: The concentration of ropivacaine administered ranged from 0.1 to 0.2%. The EC50 [95% confidence interval (CI)] determined by four statistical methods (centered isotonic, exponential regressions, linear-logarithmic, and linear regression) was 0.115, 0.113% (0.108, 0.343%), 0.142% (0.112, 0.347%), and 0.129% (0.103, 0.359%), respectively. Among all models, the residual standard error was the smallest for the exponential regression (0.2243). Conclusion: The EC50 of ropivacaine in US-guided sciatic nerve block was 0.113–0.142%, and exponential regression model best matched the data.

8 July 2020 in Aging
Verified
Journal Article
Open access
TCTingting Chen
Tingting Chen
ZZZhangxiang Zhao
Zhangxiang Zhao
BCBo Chen
Bo Chen
YWYuquan Wang
Yuquan Wang
FYFan Yang
Fan Yang
YGYunyan Gu
Yunyan Gu
The epithelial-mesenchymal transition (EMT) process is involved in cancer cell metastasis and immune system activation. Hence, identification of gene expression signatures capable of predicting the EMT status of cancer cells is essential for development of therapeutic strategies. However, quantitative identification of EMT markers is limited by batch effects, the platform used, or normalization methods. We hypothesized that a set of EMT-related relative expression orderings are highly stable in epithelial samples yet are reversed in mesenchymal samples. To test this hypothesis, we analyzed transcriptome data for ovarian cancer cohorts from publicly available databases, to develop a qualitative 16-gene pair signature (16-GPS) that effectively distinguishes the mesenchymal from epithelial phenotype. Our method was superior to previous quantitative methods in terms of classification accuracy and applicability to individualized patients without requiring data normalization. Patients with mesenchymal-like ovarian cancer showed poorer overall survival compared to patients with epithelial-like ovarian cancer. Additionally, EMT score was positively correlated with expression of immune checkpoint genes and metastasis. We, therefore, established a robust EMT 16-GPS that is independent of detection platform, batch effects and individual variations, and which represents a qualitative signature for investigating the EMT and providing insights into immunotherapy for ovarian cancer patients.

1 March 2023 in ASVIDE
Verified
Journal Article
Closed access
CXCheng Xu
Cheng Xu
ZWZichen Wang
Zichen Wang
CWChengyu Wang
Chengyu Wang
JLJie Lu
Jie Lu
QZQuanhong Zhou
Quanhong Zhou